Euclidean Capital LLC - Apr 28, 2021 Form 3 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: 10%+ Owner
Signature: /s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager
Stock symbol: PMVP
Transactions as of: Apr 28, 2021
Transactions value $: $0
Form type: 3
Date filed: 5/7/2021, 04:51 PM
Next filing: Jun 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PMVP	Common Stock						694K	Apr 28, 2021	See footnotes	F1, F6
holding	PMVP	Common Stock						2.6M	Apr 28, 2021	See footnotes	F2, F6
holding	PMVP	Common Stock						751K	Apr 28, 2021	See footnotes	F3, F6
holding	PMVP	Common Stock						133K	Apr 28, 2021	See footnotes	F4, F6
holding	PMVP	Common Stock						494K	Apr 28, 2021	See footnotes	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
F2	The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean.
F3	The shares are held of record by Greenland FP LLC, which is managed by Euclidean.
F4	The shares are held of record by Greenland NFP LLC, which is managed by Euclidean.
F5	The shares are held of record by Symmetry Group Ltd ("Symmetry"). Mrs. Simons and Mr. Simons are on the board of directors of Symmetry's parent.
F6	Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein.